This report highlights key achievements registered by the Ministry of Health, affiliated institutions, implementing agencies both at central and decentralized levels in 2013-2014. Generally, the Health Sector accomplishments and programs routine data for 2013-2014 confirm that Rwanda maintains its p...rogress towards the realization of health-related MDGs and national health targets as well.
more
The concept of mental disorder is determined by many factors, including the historical context, cultural influence, level of scientific knowledge and capacity to carry out scientific enquiry, level of education in certain circumstances, as well as many others. In putting together a method of classif...ication of mental disorders, the expert’s duty is primarily that of capturing and remaining faithful to the current level of knowledge in the subject, acknowledging that, in a matter of time, some or all the above factors could change to variable degrees, making what was clear as a mental disorder a few decades previously less clear in the next edition of the classification system.
more
CYCLONE IDAI
1.85M People affected; 400K Displaced; 603 Deaths; 1641 Injured; 1.2M People in need; 6766 Cholera cases; 43556 Malaria case
CYCLONE KENNETH
3214 Displaced; 45 Deaths; 91 Injured; 374K People in need; 225 Cholera cases; 7279 Malaria case
Tuberculosis (TB) is the leading cause of illness and death among people living with HIV. TB can be cured.
Global Fund Investment Guidance for Eastern Europe and Central Asia
Accessed: 29.09.2019
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...(30%) had dolutegravir HIVDR. Malawi urgently requires adequate HIVDR testing capacity.
more
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
To provide quality maternal and newborn health services at health facilities in India.
Emergency assistance needs are anticipated to be atypically high through 2019/20 lean season.
The 2018/19 rainy season was marked by a delayed start of season, below average rainfall, early cessation of rains, and heavy late season rainfall and flooding associated with Tropical Cyclones Desmond, I...dai, and Kenneth.
In most of the south, rainfall was delayed and erratic resulting in a reduction of area planted as well as poor germination, crop establishment, and multiple planting attempts. Additionally, mid-season dryness resulted in poor cropping conditions along with permanent wilting and crop failure in localized areas.
more
This guideline aims to improve the quality of donations and the management thereof and serve as the basis for policies of the State and other organizations in the giving and receiving of donations of medicines, medical devices and IVDs.
Over the last three or four decades, there has been an enorm...ous increase in scientific knowledge about the mode of action, effects and side effects of medicines, medical devices and IVDs. It is important for all
stakeholders to understand that these products have both benefits and risks, that they have to be used carefully and appropriately and that some can do more harm than good.
There are many different scenarios for the donation of medicines, medical devices and IVDs. Donations may take place in acute emergencies or as part of development aid in non-emergency situations. They may involve donations (i.e. direct or through private voluntary organizations), aid by governments or persons authorized to sell medicines, medical devices and/or IVDs.
more
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world